Class Certification Granted In Exchange Act Suit Related To Teva FCA Violations
PHILADELPHIA — A Pennsylvania federal judge granted class certification in a putative class action alleging that Teva Pharmaceuticals Industries Ltd. and its executives violated the Securities Exchange Act by artificially raising...To view the full article, register now.
Already a subscriber? Click here to view full article